The US Army Small Business Innovation Research (SBIR) office and the U.S. Army Telemedicine and Advanced Technology Research Center (TATRC) have awarded a Phase II SBIR grant worth approximately $1 Million to RE2 Robotics.

The grant will help advance the development of RE2’s medical module payload called LIFELINE, which is designed to help combat medics treat wounded and injured soldiers in the battlefield.

“Our team is honored that the Army has selected RE2 once again to further develop technology to help improve the safety of our brave military personnel while in hazardous combat situations,” says President and CEO of RE2 Jorgen Pedersen, via press release.

“The LIFELINE technology, in addition to our Patient Assist Robotic Arm and the ARIBO Assistive Arm programs, further extends our reach into the Healthcare market.”

Originally developed during Phase I of this SBIR program, LIFELINE is meant to make the process of maneuvering and evacuating wounded soldiers easier for combat medics. LIFELINE is designed for military ground vehicles, and will allow one combat medic to evacuate a combat casualty, as opposed to two combat medics.

The main emphasis of Phase II will be to reduce the weight of the payload to help take the burden off of a soldier during installation. The final prototype of the payload is expected to be complete by the end of Phase II.

<< Back to the News